Direct thrombin inhibitor reduced relative risk of venous thromboembolism
An investigational direct thrombin inhibitor reduced relative risk of venous thromboembolism after total hip replacement surgery by 65.7%—compared to a currently available treatment.
Fuji, T et al. Efficacy and Safety of Edoxaban Verus Enoxaparin for the Prevention of Venous Thrombembolism Following Total Hip Arthroplasty: STARS J-V Trial. Orlando, Florida: American Society of Hematology,2010 Annual Meeting; December 4-7, 2010. http://ash.confex.com/ash/2010/webprogram/Paper29404.html